Email this article to a friend
13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
-
* Corresponding author: Barbara Jarzab bjarzab@io.gliwice.pl
Thyroid Research 2009, 2:8 doi:10.1186/1756-6614-2-8